IP Library Granted Patent US 9,884,864
Granted Patent B2
US 9,884,864 · App. 15/454,703 · Granted Feb 6, 2018

Antibacterial cyclopenta[C]pyrrole substituted 3,4-Dihydro-1H-[1,8]naphthyridinones

Inventors: Jerôme Emile Georges Guillemont (Ande, FR); David Francis Alain Lançois (Louviers, FR); Magali Madeleine Simone Motte (Louviers, FR); Anil Koul (Edegem, BE); Wendy Mia Albert Balemans (Kalmthout, BE); Eric Pierre Alexandre Arnoult (Le Vaudreuil, FR)
Assignee: Janssen Sciences Ireland UC
C07D471/04C07D519/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,884,864
App. No.
15/454,703
Granted
Feb 6, 2018
Kind
B2
Abstract

The present invention is related to novel compounds of formula (I) that inhibit the activity of the FabI enzyme which are therefore useful in the treatment of bacterial infections. It further relates to pharmaceutical compositions comprising these compounds, and chemical processes for preparing these compounds.

Claims (4)

1. A compound selected from the group consisting of:

and pharmaceutically acceptable salts thereof.

2. A pharmaceutical composition comprising a pharmaceutically acceptable excipient and an effective amount of a compound selected from the group consisting of:

and pharmaceutically acceptable salts thereof.

Assignments (11)
CHANGE OF NAME Recorded Mar 6, 2019
From: JANSSEN SCIENCES IRELAND UC
To: JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
Reel/Frame 048523/0408 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2018
From: KOUL, ANIL
To: JANSSEN PHARMACEUTICA NV
Reel/Frame 046576/0468 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2018
From: BALEMANS, WENDY MIA ALBERT
To: JANSSEN INFECTIOUS DISEASES - DIAGNOSTICS BVBA
Reel/Frame 046576/0489 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2018
From: JANSSEN PHARMACEUTICA NV
To: JANSSEN R&D IRELAND
Reel/Frame 046576/0502 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2018
From: JANSSEN INFECTIOUS DISEASES - DIAGNOSTICS BVBA
To: JANSSEN R&D IRELAND
Reel/Frame 046576/0769 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2018
From: GUILLEMONT, JERÔME EMILE GEORGES
To: JANSSEN-CILAG
Reel/Frame 046576/0789 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2018
From: LANÇOIS, DAVID FRANCIS ALAIN
To: JANSSEN-CILAG
Reel/Frame 046576/0796 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2018
From: MOTTE, MAGALI MADELEINE SIMONE
To: JANSSEN-CILAG
Reel/Frame 046576/0835 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2018
From: JANSSEN-CILAG
To: JANSSEN R&D IRELAND
Reel/Frame 046576/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2018
From: ARNOULT, ERIC PIERRE ALEXANDRE
To: JANSSEN-CILAG
Reel/Frame 046576/0874 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2018
From: JANSSEN R&D IRELAND
To: JANSSEN SCIENCES IRELAND UC
Reel/Frame 046576/0963 →
Priority Claims (1)
EP 11177119 · Aug 10, 2011 · regional
Continuity (4)
Continuation 15071612 · Mar 16, 2016
Continuation 14552108 · Nov 24, 2014
Continuation 14237862
Related Publication 20170174683A1 · Jun 22, 2017